形成耐多药结核或广泛耐药结核的第二个途径是患者自身的结核产生耐药性。
A second way of developing MDR-TB or XDR-TB is when a patient's own TB develops resistance.
但由于水溶性差、易产生多药耐药性和毒性较强等缺点限制了它们在临床上的应用。
However, their therapeutic use is often hindered by problems such us poor water solubility, acquired drug-resistance and strong toxicity.
两株耐药细胞对5-氟尿嘧啶、甲氨蝶呤产生了耐药，具有多药耐药性的特点；
Two cell lines with the characteristics of multi-drug resistance resistant to 5-fluorouracil and methotrexate;
两株耐药细胞对5-氟尿嘧啶、甲氨蝶呤产生了耐药，具有多药耐药性的特点；
Two cell lines with the characteristics of multi-drug resistance resistant to 5-fluorouracil and methotrexate;
应用推荐